The European startup wants to decrease the time-and the number of miles-it takes to deliver parcels to consumers.

CAMBRIDGE, MA—Sanjiv Patel, President and CEO of Relay Therapeutics, Inc. (NASDAQ:RLAY), a $656 million market cap biotech company currently trading at $3.96, recently executed notable stock ...

CAMBRIDGE, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining ...

An example is how Relay has streamlined operations to extend its cash runway. A 15% workforce reduction and R&D prioritization resulted in $50 million in expected annual savings for the company.

The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events ...

Relay Therapeutics (NASDAQ:RLAY – Get Free Report) had its price objective decreased by equities researchers at Stifel ...

Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the company, Ratings reports.

Founded by CEO Jonathan Jenssen and COO Nicole Mazza, who both previously worked at last-mile delivery company Stuart, Relay is now clearly entering its AI-driven scale-up phase. Most delivery ...

The buck stops at truck stops when using this company’s anti-fraud app Relay Payments, which is digitizing truck stop transactions, is one of Fast Company's Most Innovative Companies in logistics.